UF Researchers Receive NCI Grant to Study microRNA Degradation in Acute Lymphoblastic Leukemia
A team of University of Florida researchers has received a five-year $2.5 million grant from the National Cancer Institute to study gene regulation in acute lymphoblastic leukemia (ALL).
UF Health Cancer Center Achieves National Cancer Institute Designation
The University of Florida Health Cancer Center has received a prestigious designation from the National Cancer Institute, or NCI, and joins the ranks of the country’s most distinguished cancer centers, becoming the 72nd in the United States and the only one in North Central Florida.
Genetic Mutation Could Play Role in Improving Leukemia Treatment, UF Health Researchers Find
In the battle against one type of leukemia, a genetic mutation could hold the key to more effective, lower-dose treatments. The new, early findings by University of Florida Health researchers and their colleagues are especially relevant for older or frail patients who may not be able to tolerate high-dose chemotherapy.